STORY HIGHLIGHTS
August 18, 2020. Kiram Mazumdar Shaw, the Chairperson and Managing Director of Biocon is tested positive for Covid 19. The entrepreneur herself announced her Covid status.
August 18, 2020. Kiram Mazumdar Shaw, the Chairperson and Managing Director of Biocon is tested positive for Covid 19. The entrepreneur herself announced her Covid status.
In a tweet on Monday night, she said, "I have added to the Covid count by testing positive. Mild symptoms n I hope it stays that way."
Her Company is one of the three companies doing research on Covid vaccines. After her announcement, her Twitter wall was full of people wishing her a speedy recovery.
Biocon is one of the companies which is in the race of making drugs to fight COVID-19, and in July, received the approval of the Drug Controller General of India to market a repurposed injection, Itolizumab. It was originally launched in 2013 for treating chronic plaque psoriasis.
STORY HIGHLIGHTS
August 18, 2020. Kiram Mazumdar Shaw, the Chairperson and Managing Director of Biocon is tested positive for Covid 19. The entrepreneur herself announced her Covid status.
August 18, 2020. Kiram Mazumdar Shaw, the Chairperson and Managing Director of Biocon is tested positive for Covid 19. The entrepreneur herself announced her Covid status.
In a tweet on Monday night, she said, "I have added to the Covid count by testing positive. Mild symptoms n I hope it stays that way."
Her Company is one of the three companies doing research on Covid vaccines. After her announcement, her Twitter wall was full of people wishing her a speedy recovery.
Biocon is one of the companies which is in the race of making drugs to fight COVID-19, and in July, received the approval of the Drug Controller General of India to market a repurposed injection, Itolizumab. It was originally launched in 2013 for treating chronic plaque psoriasis.